ResearcherShandong UniversityNo recent work listed

Yong Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0574-2877; OpenAlex author ID A5100694769. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

Analysis of N6-methyladenosine-related lncRNAs in the tumor immune microenvironment and their prognostic role in pancreatic cancer. Co-author DOI 10.1007/s00432-022-03985-4 ↗
Radiosensitization of metformin in pancreatic cancer cells via abrogating the G2 checkpoint and inhibiting DNA damage repair. Co-author DOI 10.1016/j.canlet.2015.08.015 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jun Liu · 1 shared paper, 2022 · strength 0.20
- Paper Analysis of N6-methyladenosine-related lncRNAs in the tumor immune microenvironment and their prognostic role in pancre… DOI 10.1007/s00432-022-03985-4 ↗
Guo-Liang Jiang · 1 shared paper, 2015 · strength 0.05
- Paper Radiosensitization of metformin in pancreatic cancer cells via abrogating the G2 checkpoint and inhibiting DNA damage r… DOI 10.1016/j.canlet.2015.08.015 ↗
Dongping Wei · 1 shared paper, 2015 · strength 0.05
- Paper Radiosensitization of metformin in pancreatic cancer cells via abrogating the G2 checkpoint and inhibiting DNA damage r… DOI 10.1016/j.canlet.2015.08.015 ↗
Wang Zheng · 1 shared paper, 2015 · strength 0.05
- Paper Radiosensitization of metformin in pancreatic cancer cells via abrogating the G2 checkpoint and inhibiting DNA damage r… DOI 10.1016/j.canlet.2015.08.015 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.